Related references
Note: Only part of the references are listed.Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
Evgeny Krupitsky et al.
LANCET (2011)
Oral naltrexone maintenance treatment for opioid dependence
Silvia Minozzi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Richard P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics
Michael R. Lucey et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
R. P. Mattick et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Management of relapse in naltrexone maintenance for heroin dependence
Maria A. Sullivan et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Efficacy and tolerability of long-acting injectable for alcohol dependence - A randomized controlled trial
JC Garbutt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies
HC Wilcox et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
Naltrexone for heroin dependence treatment in St. Petersburg, Russia
EM Krupitsky et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2004)
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
PJ Fudala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
